Primary Central Nervous System Lymphoma

DBCOND0028650Hemic and Lymphatic DiseasesImmune System Diseases

Primary Central Nervous System Lymphoma is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Primary Central Nervous System Lymphoma (PCNSL) · PCNSL (Primary CNS Lymphoma) · Primary CNS Lymphoma (PCNSL) · Primary CNS Lymphoma · Primary Central Nervous Lymphoma
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10C83.390SNOMED CT190006007MedDRA10007953UMLSC0280803

What you can answer from here — as of October 30, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
134Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Primary Central Nervous System Lymphoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In